本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Kalvista Pharmaceuticals Inc

15.39
-0.6200-3.87%
盤後15.400.0100+0.06%17:57 EDT
成交量:127.91萬
成交額:2,012.97萬
市值:7.66億
市盈率:-4.17
高:16.23
開:15.90
低:15.30
收:16.01
資料載入中...
2020/09/14

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/07/02

重要事件披露

8-K - Current report
2020/07/01

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/06/11

重要事件披露

8-K - Current report
2020/04/10

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/03/23

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/03/10

員工持股計劃

Securities to be offered to employees in employee benefit plans
2020/03/10

重要事件披露

Current report, items 2.02 and 9.01
2020/03/10

季度報告

Quarterly report [Sections 13 or 15(d)]
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/13

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/13

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/07

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/04

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/12/03

季度報告

Quarterly report [Sections 13 or 15(d)]
2019/12/03

重要事件披露

Current report, items 2.02 and 9.01
2019/10/03

重要事件披露

Current report, item 5.07
2019/09/09

重要事件披露

Current report, items 2.02 and 9.01
2019/09/09

季度報告

Quarterly report [Sections 13 or 15(d)]
2019/07/30

持股變動聲明

Statement of changes in beneficial ownership of securities